Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,455 signal articles · 146 in last 24h · 154,143 total before filter · latest 1h ago

146last 24h

875last 7d

147● bullish (7d)

96● bearish (7d)

214publishers

All Macro211 Earnings108 M&A125 Regulatory21 Product21 Analyst17

✕ clear all filtersticker: GENBSentiment:bullish neutral bearish ✓ showing all (incl. clickbait)

Insider Monkey93d agoneutral

Morgan Stanley Maintains an Overweight Rating on Generate Biomedicines, Inc. (GENB)

Generate Biomedicines, Inc. (NASDAQ:GENB) is one of the 12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On. On May 14, Morgan Stanley increased its price objective on Generate Biomedicines, Inc. (NASDAQ:GENB) to $22 from $20. The firm maintained an “Overweight” rating on the shares. Separately, Generate Biomedicines, Inc. (NASDAQ:GENB)’s GB-0895 (anti-TSLP) program […]

GENB